Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Really? Why did they do two small offering in the last couple of months.
So you are out. Smart! I am talking about reality.
More delays mean more dilution. They have no other choices! SP might go down to sub penny before the binary event happens. They do NOT have enough cash!
LOL. Keep blinded.
Your logic says it all. No further comment.
"Nader has his life invested in this deal"??? LMFAO!!!
Are you even real?! If this Nadar guy has a little bit of confidence on this PRO-140, why did he even put a dime on such a bargain SP, what? 60 something cents!
From FDA this week for what? BTD! Be real and rational. Trust me the BTD will not do anything to SP if you are a long-term believer. If you are a pump and dump, then remember to sell in the first 30 minutes of trading when they announce BTD granted although I doubt they will get BTD.
Can't agree more. This company's financial structure and financial strategy is a pure disaster to the share holders. If they miss the primary end point in combo, it will be a pure garbage.
Nice day dream.
First, BTD is not a sure thing, 50-50. Second, even if granted, SP might jump 20-30% and then fall back down in the first couple of hours of trading. The day may close green or red.
The only thing that can save this company is positive primary end points for combo that this P promised in multiple occasions by end of this quarter. Although I believe he may not be able to deliver 1H of this year. Let us see in June. Mark this post.
Man, I really wish you are right?! BTW, I long CYDY since more than a year ago and still holding. But I just pointed out the fact. 95% of clinical stage biotech are scam until they prove themselves they are not!
We will know in a couple of months. I certainly hope not.
Forgot to mention the company's financial structure and warrants are purely disaster to the current shareholders.
So we will know in a couple of months whether or not this is a scam?!
Why everybody think BTD is such a big deal? If BTD is granted, SP might jump up 30-40% and then back down. Based on history, BTD drug did have a 30% of chance to FDA approval. I just can't understand why everybody thinks BTD is such a high deal. If the PIII adjunct fails, this will be a pure garbage. Worthless. Period.
You may be right!! You'd better sell and run!
Best post of all time!!! Great job!!!
Yes per company's latest presentation.
It's way undervalued. Market will correct it eventually. If both P2 data are positive, It should be in the 5~10 ranges.
Good vol today. Hope it continues.
Thanks for the info! Greatly appreciated!
Thanks!!!
I like Nadar's no RS strategy. He mentioned it in one of the conference call that the SP will get hammered down if they RS and uplist to NYSE or NASDAQ, Which I completely agree.
Higher SP will give more room for short sellers to short.
RS or not will not change the company's fundamental at all. If PRO-140 is as good as Nadar claimed, SP will eventually increase.
One thing that really worries me is the patient drop rate in their P2b, started with 40 or so patients and down to something like 10 patients! NASCAR never mentioned why this high drop rate!! Plus, FDA is also very concern about this patient drop (according to Nadar's word in one of the recent conference call). Hope this won't happen in the two P3's. otherwise Nadar may be hiding something!!!
Positive P3 efficacy data for combo should push this to $6 and beyond. That should be way before FDA submission
Really? I have used my IRA to buy CYDY. No issue at all!
I found very entertaining reading your posts. Keep up the good work!
So did you buy at the pump and sell the dump?
Did he update at ST? Do you have a link? Thanks a lot!
0.40 really?? We shall see.
Sorry. I was just teasing with him/her. I am long with a very big lot.
No. they are not. Be careful.
Yeah. At this price, he should buy more or use stock to replace some of his cash compensations.
Thanks! So, as long as he still has that many of shares, dilution or LPC deal would be one of the last things he would consider. So not too bad.
Does anyone know that Missling still holds his 4millions or so shares? Or has he already sold?
Someone is loading the boat.
And to add, ATM is a better choice than LPC deal.
Finally see some rational analysis. Thanks for the analysis! At this point, ATM has a much higher chance than partnership, etc. for funding the P2b/P3.
by looking at the poster, it appears that 2-73 alone did a much better job on both scores as compared to the plus. I know the sample size is too small to draw any conclusion. But at the least, it showed something promising! Sample size looks like half of the plus' patient number. Maybe only 7-8 patients in 2-73 alone. But, at least, Not sure why the company did NOT mentioned this at all.
Another thing that really concerns me is that the zoom out the scale on the y-axis of all their plots to make them look flat!!
So tell me why the endless price drop? Manipulation? give me a break!
Because it's a scam!!!!
Are we at $10-$20 yet.